% Expired Patents = 66.7

EPO Patents = 5

Forward Citations = 3

Loading Chart...

15 inventors (with patents filed for the assignee):

Mehdi Chenik (4 out of 4 patents)

Hechmi Louzir (4 out of 4 patents)

Koussay Dellagi (4 out of 4 patents)

4. Yosser Ben Achour (2 out of 2 patents)

5. Jose-Alain Sahel (1 out of 44 patents)

6. Xavier Guillonneau (1 out of 4 patents)

7. Naziha Marrakchi (1 out of 1 patent)

8. Fadoua Montassar (1 out of 1 patent)

9. Erij Messadi (1 out of 1 patent)

10. Florian Sennlaub (1 out of 10 patents)

11. Jean-Loup Lemesre (1 out of 7 patents)

12. Sami Lakhal (1 out of 1 patent)

13. Rachel Bras Gonçalves (1 out of 1 patent)

14. Amel Garnaoui (1 out of 1 patent)

15. Elodie Petitdidier-Lesin (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 11559575 - Multi-epitopic peptide compounds and vaccines against leishmaniasis (2023-01-24),

2. 11191807 - Lebecetin, a C-type lectin, as neovascularization inhibitor (2021-12-07),

3. 8715697 - Genes associated with Leishmania parasite virulence (2014-05-06),

4. 8551500 - Composition comprising the N-terminal region of histone H2B of leishmania—use thereof for inducing an immune response (2013-10-08),

5. 7888492 - [object Object] (2011-02-15),

6. 7700121 - Gene associated with leishmania parasite virulence (2010-04-20),

Institut Pasteur De Tunis is a leading research institution in Tunisia, dedicated to the study of infectious diseases and the development of vaccines. Established in 1893, the institute conducts cutting-edge research in microbiology, immunology, and epidemiology. It also provides diagnostic services and training programs for healthcare professionals. Institut Pasteur De Tunis plays a crucial role in public health and disease prevention in Tunisia and the region.

Profile summary based on public USPTO records.